BioForce Nanosciences Becomes Publicly Traded Company.AMES, Iowa Ames is a city located in the central part of the U.S. state of Iowa, about 30 miles north of Des Moines in Story County. It is the principal city of the 'Ames, Iowa Metropolitan Statistical Area' which encompasses all of Story County, Iowa and which, when combined with the -- BioForce Nanosciences, Inc. (BioForce) has become a publicly traded company publicly traded company A company whose shares of common stock are held by the public and are available for purchase by investors. The shares of publicly traded firms are bought and sold on the organized exchanges or in the over-the-counter market. following its recently announced acquisition by Silver River Ventures, Inc., now known as BioForce Nanosciences Holdings, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). symbol "BFNH"). BioForce will operate as the wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of BFNH. The agreement was contingent upon Adj. 1. contingent upon - determined by conditions or circumstances that follow; "arms sales contingent on the approval of congress" contingent on, dependant on, dependant upon, dependent on, dependent upon, depending on, contingent the receipt of $2.5 million in escrow funds Noun 1. escrow funds - funds held in escrow cash in hand, finances, funds, monetary resource, pecuniary resource - assets in the form of money prior to the finalization of the acquisition process. Opportunities remain for additional private placement capital and a secondary offering is anticipated to occur in late 2006. BioForce, founded in 1994 by Eric Henderson Eric Henderson (born January 8, 1983 in New Orleans, Louisiana) is a linebacker on the Cincinnati Bengals. He played college football at Georgia Tech, where he was part of a dominating Jon Tenuta defense. He was All-ACC first team in 2003, and All-ACC second team in 2004 and 2005. , Ph.D., is a revenue-generating company and has sales pending in the United States and internationally. "BioForce has followed the tried and true model of beginning with a vision, then working for funding through grants, seed capital and other sources to fund research on nascent technology," said Dr. Henderson, who continues as Chief Executive Officer and Chief Science Officer of BioForce. "After 11 years, we are now reaching our long-term goal of bringing the first wave of new and innovative products to market." BioForce's cornerstone technology, the NanoArrayer(TM) System, is a biomolecular printing tool poised to impact the arena of cell biology with applications in molecular and cellular detection in a variety of clinical and non-clinical installations. Other products include the ViriChip(TM) System, the company's proprietary ultra-micro detection system for viruses, and consumable printing tools and print surfaces, including proprietary SPT (Sectors Per Track) The number of sectors in one track. (TM) Surface Patterning Tools and Sindex(TM) Chips. "As a public company, we have new responsibilities, but also access to the advantages that come from the liquidity of public market," Dr. Henderson said. "We will continue working to leverage these new opportunities for future growth of the company." Silver River Ventures President Ed Cowle said, "We are very pleased to be a part of this innovative bionanotechnology company. The team at BioForce has developed a strong portfolio of intellectual property and leveraged this value into marketable products." About BioForce Nanosciences: BioForce Nanosciences Inc. has patented and patent-pending technology and products for ultramicro- and nanoscale placement and patterning of active biomolecules This page aims to list articles on Wikipedia that describe particular biomolecules or types of biomolecules. This list is not necessarily complete or up to date - if you see an article that should be here but isn't (or one that shouldn't be here but is), please update the page and other materials. This technology is embodied in the NanoArrayer(TM) System, a proprietary instrumentation/software platform. As an industry leader in the emerging field of bionanotechnology, BioForce Nanosciences is focused on providing practical molecular printing tools to the biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. and life sciences markets. The company offers a line of accessory products for atomic force microscopy and the innovative NanoArrayer(TM) System with specialty consumable products as a cornerstone of the company. Contact BioForce Nanosciences at info@bioforcenano.com or 515-233-8333. For more information, visit www.bioforcenano.com. This news release contains forward-looking information that may be affected by certain risks and uncertainties, including those risks and uncertainties described in the company's most recent filings with the Securities and Exchange Commission. The company's actual results could differ materially from such forward-looking statements. We assume no duty to update these statements at any future date. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion